(Total Views: 477)
Posted On: 06/27/2022 3:23:39 PM
Post# of 148987
If they feel "threatened" they don't "come in and buy." They just get their stooges at the FDA to slow-walk things, while hedge fund tweeters bash the stock and short it.
Take a look at Novavx. FDA asked for additional information about manufacturing a couple of weeks ago, which NVAX provided in 1 day. FDA still has not approved their non-mRNA vaccine -- a traditional-type vaccine already approved in 41 countries -- despite the unanimous opinion by the advisory committee to approve it.
Meanwhile, they approved Pfizer's and Moderna's vaccines for younger kids in just a couple of days, and are giving the go-ahead to Pfizer's Omicron-focused booster. Oh, I forgot to mention -- they approved Moderna's kid vaccine that has only 37% efficacy, though they said that the threshold for approval is 70% efficacy.
What's Novavax's efficacy? 92%.
So, if you think there are not concerted efforts against certain companies' drugs -- please think about this, look at how the FDA has treated CYDY, and read my previous post 125486 that's down a couple of slots.
Take a look at Novavx. FDA asked for additional information about manufacturing a couple of weeks ago, which NVAX provided in 1 day. FDA still has not approved their non-mRNA vaccine -- a traditional-type vaccine already approved in 41 countries -- despite the unanimous opinion by the advisory committee to approve it.
Meanwhile, they approved Pfizer's and Moderna's vaccines for younger kids in just a couple of days, and are giving the go-ahead to Pfizer's Omicron-focused booster. Oh, I forgot to mention -- they approved Moderna's kid vaccine that has only 37% efficacy, though they said that the threshold for approval is 70% efficacy.
What's Novavax's efficacy? 92%.
So, if you think there are not concerted efforts against certain companies' drugs -- please think about this, look at how the FDA has treated CYDY, and read my previous post 125486 that's down a couple of slots.
(9)
(0)
Scroll down for more posts ▼